Science & Research

A Florida company has announced clinical trials for the first-ever drug seeking to treat cannabis use disorder.

A recent report found the international medical cannabis market could grow an estimated 19% from 2022 to 2028 to reach a $40 billion global value.

The California Department of Cannabis Control has earmarked $20 million in funding for research prioritizing multiple cannabis topics including potency, health impacts, medicinal use, legacy cannabis genetics, and the health of California’s cannabis industry.

Adult-use cannabis sales launched in Vermont over the weekend; at least 70 Vermont municipalities have opted to allow retail cannabis sales.

Rutgers University researchers found a 2% increase in home prices where municipalities have allowed licensed cannabis businesses to operate compared to areas that instituted bans on the industry.

A recent study by UK researchers found that cannabis consumption is not associated with increased apathy among adults and adolescents.

Active cannabis consumers fared better against COVID-19 than non-consumers according to preliminary research published this month in the Journal of Cannabis Research.

Michigan is giving $12.5 million to two universities to facilitate research into the potential therapeutic benefits of cannabis for veterans suffering from PTSD.

Filament Health has begun its Phase 1 study investigating naturally-derived psilocin and psilocybin, the first such study ever approved by the FDA.

A recent UN report noted an uptick in cannabis consumption tied to the COVID-19 pandemic as well as legalization policies around the world.

A special report by Project CBD details the chemistry of cannabinoids and how a concept called chirality enables the synthetic production of new cannabinoids like Delta-8 THC; the report also highlights the risk of potentially unleashing new, “hidden dangers” in the process.

A recent New Frontier Data report found that 39% of millennials who are cannabis consumers typically use cannabis multiple times per day.

A new poll found that 91% of adults who have consumed cannabis have done so for health and/or wellness purposes.

A study from the University of New Mexico found that individuals with THC in their system scored higher than non-users on moral decision-making, pro-social behaviors, and empathy.

A recent study into cannabis-related content on TikTok has found the plant to be portrayed positively, with humor/entertainment videos comprising the majority of the content.

According to research published in the Journal of Adolescent Health, cannabis legalization in Washington state has not led to increases in the use of alcohol and cigarettes or abuse of pharmaceutical painkillers.

The National Institutes of Health has announced a notice of special interest for funding studies investigating the risk of cannabis treatments for cancer patients.

Consuming cannabis flower has been shown to improve symptoms of fatigue in 91% of study participants, according to new research by the University of New Mexico.

Maridose LLC, based in Florida, is close to obtaining DEA approval to cultivate cannabis for research purposes in Maine.

The majority of CBD products marketed for sleep are inaccurately labeled for CBD, CBN, or melatonin content, according to a recent study by Leafreport.

Kentucky Gov. Andy Beshear (D) signed legislation this week to create a cannabis research center at the University of Kentucky.

Legalizing adult-use cannabis lowers the demand for prescription drugs through state Medicaid programs, according to a recent study.

A recent study by the Kansas State University College of Veterinary Medicine found that feeding cattle CBDA-rich hemp decreased the animals’ stress hormone cortisol and inflammation biomarkers.

The U.S. House approved a bipartisan cannabis research bill this week that would expand research possibilities and let researchers study cannabis products acquired through state-legal markets.